| Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures D Marshall, O Johnell, H Wedel Bmj 312 (7041), 1254-1259, 1996 | 4807 | 1996 |
| Conjoint analysis applications in health—a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force JFP Bridges, AB Hauber, D Marshall, A Lloyd, LA Prosser, DA Regier, ... Value in health 14 (4), 403-413, 2011 | 1670 | 2011 |
| Constructing experimental designs for discrete-choice experiments: report of the ISPOR conjoint analysis experimental design good research practices task force FR Johnson, E Lancsar, D Marshall, V Kilambi, A Mühlbacher, DA Regier, ... Value in health 16 (1), 3-13, 2013 | 1581 | 2013 |
| Statistical methods for the analysis of discrete choice experiments: a report of the ISPOR conjoint analysis good research practices task force AB Hauber, JM González, CGM Groothuis-Oudshoorn, T Prior, ... Value in health 19 (4), 300-315, 2016 | 1012 | 2016 |
| Using real‐world data for coverage and payment decisions: the ISPOR real‐world data task force report LP Garrison Jr, PJ Neumann, P Erickson, D Marshall, CD Mullins Value in health 10 (5), 326-335, 2007 | 795 | 2007 |
| Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti‐rheumatic drugs for rheumatoid arthritis: A network meta‐analysis GS Hazlewood, C Barnabe, G Tomlinson, D Marshall, DJA Devoe, ... Cochrane Database of Systematic Reviews, 2016 | 366 | 2016 |
| Conjoint analysis applications in health—how are studies being designed and reported? An update on current practice in the published literature between 2005 and 2008 D Marshall, JFP Bridges, B Hauber, R Cameron, L Donnalley, K Fyie, ... The Patient: Patient-Centered Outcomes Research 3, 249-256, 2010 | 349 | 2010 |
| Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation E Fenwick, DA Marshall, AR Levy, G Nichol BMC health services research 6, 1-8, 2006 | 314 | 2006 |
| Cost-effectiveness of nurse practitioners in primary and specialised ambulatory care: systematic review R Martin-Misener, P Harbman, F Donald, K Reid, K Kilpatrick, N Carter, ... BMJ open 5 (6), e007167, 2015 | 265 | 2015 |
| Applying dynamic simulation modeling methods in health care delivery research—the SIMULATE checklist: report of the ISPOR simulation modeling emerging good practices task force DA Marshall, L Burgos-Liz, MJ IJzerman, ND Osgood, WV Padula, ... Value in health 18 (1), 5-16, 2015 | 247 | 2015 |
| Reliability and validity of the EQ-5D-5L compared to the EQ-5D-3L in patients with osteoarthritis referred for hip and knee replacement BL Conner-Spady, DA Marshall, E Bohm, MJ Dunbar, L Loucks, ... Quality of Life Research 24, 1775-1784, 2015 | 194 | 2015 |
| Cost‐effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States DA Marshall, SH Kleinman, JB Wong, JP AuBuchon, DT Grima, NA Kulin, ... Vox sanguinis 86 (1), 28-40, 2004 | 182 | 2004 |
| The clinical effectiveness and cost‐effectiveness of clinical nurse specialist‐led hospital to home transitional care: a systematic review D Bryant‐Lukosius, N Carter, K Reid, F Donald, R Martin‐Misener, ... Journal of evaluation in clinical practice 21 (5), 763-781, 2015 | 176 | 2015 |
| EUR-ASSESS project subgroup report on dissemination and impact A Granados, E Jonsson, HD Banta, L Bero, A Bonair, MC Cochet, ... International Journal of Technology Assessment in Health Care 13 (2), 220-286, 1997 | 172 | 1997 |
| Measuring patient preferences for colorectal cancer screening using a choice‐format survey DA Marshall, FR Johnson, KA Phillips, JK Marshall, L Thabane, NA Kulin Value in health 10 (5), 415-430, 2007 | 170 | 2007 |
| Selecting a dynamic simulation modeling method for health care delivery research—Part 2: Report of the ISPOR dynamic simulation modeling emerging good practices task force DA Marshall, L Burgos-Liz, MJ IJzerman, W Crown, WV Padula, PK Wong, ... Value in health 18 (2), 147-160, 2015 | 156 | 2015 |
| Cost-effectiveness of rhythm versus rate control in atrial fibrillation DA Marshall, AR Levy, H Vidaillet, E Fenwick, A Slee, G Blackhouse, ... Annals of Internal Medicine 141 (9), 653-661, 2004 | 142 | 2004 |
| Therapies for treatment of osteoporosis in US women: cost-effectiveness and budget impact considerations. AN Tosteson, RT Burge, DA Marshall, R Lindsay The American journal of managed care 14 (9), 605-615, 2008 | 135 | 2008 |
| Guidelines for conducting pharmaceutical budget impact analyses for submission to public drug plans in Canada DA Marshall, PR Douglas, MF Drummond, GW Torrance, S MacLeod, ... Pharmacoeconomics 26, 477-495, 2008 | 123 | 2008 |
| Economic decision analysis model of screening for lung cancer D Marshall, KN Simpson, CC Earle, CW Chu European Journal of Cancer 37 (14), 1759-1767, 2001 | 123 | 2001 |
Claire E H BarberUniversity of CalgaryVerified email at ucalgary.ca
